Literature DB >> 6181145

Alterations of interferon production in a mouse model of thermal injury.

F Suzuki, R B Pollard.   

Abstract

The effect of thermal injury on the response of interferon (IFN) production in vivo and in vitro after stimulation with eight representative inducers was investigated in a mouse model. The response of mice to immune IFN (IFN-gamma) inducers, staphylococcal enterotoxin A, concanavalin A, and a specific antigen for BCG-sensitized lymphocytes (purified protein derivative) was impaired after a 30% total body surface area third-degree burn. Suppression of IFN-gamma production was observed at day 2 and persisted until day 7 after burn. Decreased IFN-gamma production correlated closely with the percentage of total body surface area burned. When virus type IFN (IFN-alpha/beta) inducers, Newcastle disease virus, polyriboinosinic-polyribocytidylic acid, 10-carboxymethyl-9-acridanone, and E. coli endotoxin, were administered to mice, no change in IFN response was observed after thermal injury. Similar results were obtained when spleen cells obtained from thermally injured mice were stimulated with IFN-gamma inducers in vitro. These studies suggest that although the capacity for IFN-alpha/beta production remains intact in thermally injured mice, IFN-gamma production may be selectively decreased in burned animals and in their spleen cells.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6181145

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Decrease of circulating dendritic cells in burn patients.

Authors:  A D'Arpa; A Accardo-Palumbo; G Amato; L D'Amelio; B Napoli; D Pileri; V Cataldo; R Mogavero; C Lombardo; F Conte
Journal:  Ann Burns Fire Disasters       Date:  2007-12-31

2.  The acute pulmonary inflammatory response to the graded severity of smoke inhalation injury.

Authors:  Joslyn M Albright; Christopher S Davis; Melanie D Bird; Luis Ramirez; Hajwa Kim; Ellen L Burnham; Richard L Gamelli; Elizabeth J Kovacs
Journal:  Crit Care Med       Date:  2012-04       Impact factor: 7.598

3.  Immunological control of methicillin-resistant Staphylococcus aureus (MRSA) infection in an immunodeficient murine model of thermal injuries.

Authors:  T Katakura; T Yoshida; M Kobayashi; D N Herndon; F Suzuki
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

4.  Interferon gamma modulates trauma-induced muscle wasting and immune dysfunction.

Authors:  Sundararajan V Madihally; Mehmet Toner; Martin L Yarmush; Richard N Mitchell
Journal:  Ann Surg       Date:  2002-11       Impact factor: 12.969

5.  Rationale, design and performance of a clinical trial to investigate interferon-gamma (Imukin) in the prophylactic treatment of severe burns-related infections.

Authors:  J D Ioannovich; R D Hinzmann; G Deichsel; G G Steinmann
Journal:  Intensive Care Med       Date:  1996-10       Impact factor: 17.440

6.  [Immune paralysis in acute pancreatitis--HLA-DR antigen expression on CD14+DR+ monocytes].

Authors:  A Richter; T Nebe; R Kattermann; M Trede
Journal:  Langenbecks Arch Chir       Date:  1996

7.  Rickettsia australis infection: a murine model of a highly invasive vasculopathic rickettsiosis.

Authors:  H M Feng; J Wen; D H Walker
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

8.  The relationship between interferon-gamma and keratinocyte alloantigen expression after burn injury.

Authors:  C S Hultman; L M Napolitano; B A Cairns; L A Brady; C Campbell; S deSerres; A A Meyer
Journal:  Ann Surg       Date:  1995-09       Impact factor: 12.969

9.  Recombinant human growth hormone modulates Th1 and Th2 cytokine response in burned mice.

Authors:  K Takagi; F Suzuki; R E Barrow; S E Wolf; D N Herndon
Journal:  Ann Surg       Date:  1998-07       Impact factor: 12.969

10.  Stimulation of non-specific resistance to tumors in the mouse using a poly(maleic-acid-styrene)-conjugated neocarzinostatin.

Authors:  F Suzuki; R B Pollard; H Maeda
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.